# A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

> **NCT00195403** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1014 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00195403
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 1014 (ACTUAL)
- **Last updated:** 2013-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00195403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00195403, "A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00195403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*